MedTrace Logo

Evaluation of Peripartum Blood Loss and Postpartum Anaemia in Macrosomia & Gemini

NCT06201910 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 575

Last updated 2025-05-07

No results posted yet for this study

Summary

Anaemia in pregnant women occurs at a haemoglobin (Hb) concentration \<11 g/dL and treatment is essential to prevent increased maternal morbidity, fetal morbidity and mortality. Studies show a distinct risk of haemorrhage in pregnant women due to increased uterine dilatation, due to twins or macrosomic singletons. Currently, prepartum anaemia management, the influence of anaemia and the administration of foreign blood concentrates are insufficiently studied. The investigators intend to conduct a monocentric retrospective analysis of this subcohort.

Conditions

  • Bloodloss in Pregnancy

Interventions

OTHER

Observation of Blood loss

Retrospetive observation of bloodloss and RBC transfusions.

Sponsors & Collaborators

  • Goethe University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2025-01-01
Completion
2025-02-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06201910 on ClinicalTrials.gov